CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 250 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $657 | -67.3% | 39,077 | -67.7% | 0.00% | -76.5% |
| Q1 2023 | $2,008 | -99.9% | 121,122 | -40.6% | 0.02% | -5.6% |
| Q2 2022 | $1,430,000 | +694.4% | 203,993 | +837.9% | 0.02% | +800.0% |
| Q1 2022 | $180,000 | -56.6% | 21,751 | -64.5% | 0.00% | -50.0% |
| Q4 2021 | $415,000 | +9.5% | 61,315 | -14.3% | 0.00% | -20.0% |
| Q3 2021 | $379,000 | +151.0% | 71,509 | +171.7% | 0.01% | +150.0% |
| Q2 2021 | $151,000 | +7.9% | 26,318 | -37.1% | 0.00% | +100.0% |
| Q4 2020 | $140,000 | +197.9% | 41,827 | +308.7% | 0.00% | 0.0% |
| Q2 2020 | $47,000 | – | 10,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |